Intuitive Surgical, Inc. (0R29.L)
USD 486.77
(0.76%)
USD 486.77
(0.76%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.96 Billion USD | 13.13% |
| 2022 | 2.61 Billion USD | 22.52% |
| 2021 | 2.13 Billion USD | 18.0% |
| 2020 | 1.81 Billion USD | 4.36% |
| 2019 | 1.73 Billion USD | 23.56% |
| 2018 | 1.4 Billion USD | 23.27% |
| 2017 | 1.13 Billion USD | 20.59% |
| 2016 | 944.9 Million USD | 12.77% |
| 2015 | 837.9 Million USD | -3.58% |
| 2014 | 869 Million USD | 17.16% |
| 2013 | 741.7 Million USD | 7.15% |
| 2012 | 692.2 Million USD | 19.55% |
| 2011 | 579 Million USD | 21.95% |
| 2010 | 474.8 Million USD | 27.08% |
| 2009 | 373.61 Million USD | 20.54% |
| 2008 | 309.94 Million USD | 49.34% |
| 2007 | 207.54 Million USD | 47.74% |
| 2006 | 140.48 Million USD | 65.67% |
| 2005 | 84.79 Million USD | 26.93% |
| 2004 | 66.8 Million USD | 19.49% |
| 2003 | 55.9 Million USD | -3.03% |
| 2002 | 57.65 Million USD | 31.52% |
| 2001 | 43.83 Million USD | 23.06% |
| 2000 | 35.62 Million USD | 56.85% |
| 1999 | 22.71 Million USD | -26.2% |
| 1998 | 30.77 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 796.6 Million USD | -1.09% |
| 2024 Q1 | 776 Million USD | -6.19% |
| 2024 Q2 | 805.4 Million USD | 3.79% |
| 2023 Q3 | 701.4 Million USD | -1.03% |
| 2023 Q2 | 708.7 Million USD | -2.3% |
| 2023 Q1 | 725.4 Million USD | -1.76% |
| 2023 FY | 2.96 Billion USD | 13.13% |
| 2023 Q4 | 827.2 Million USD | 17.94% |
| 2022 Q3 | 653.2 Million USD | 4.4% |
| 2022 Q1 | 601.6 Million USD | -1.44% |
| 2022 FY | 2.61 Billion USD | 22.52% |
| 2022 Q4 | 738.4 Million USD | 13.04% |
| 2022 Q2 | 625.7 Million USD | 4.01% |
| 2021 FY | 2.13 Billion USD | 18.0% |
| 2021 Q2 | 512.5 Million USD | 5.5% |
| 2021 Q1 | 485.8 Million USD | 1.21% |
| 2021 Q4 | 610.4 Million USD | 15.43% |
| 2021 Q3 | 528.8 Million USD | 3.18% |
| 2020 Q3 | 453.9 Million USD | 7.48% |
| 2020 FY | 1.81 Billion USD | 4.36% |
| 2020 Q1 | 455.2 Million USD | -8.67% |
| 2020 Q2 | 422.3 Million USD | -7.23% |
| 2020 Q4 | 480 Million USD | 5.75% |
| 2019 FY | 1.73 Billion USD | 23.56% |
| 2019 Q4 | 498.4 Million USD | 18.69% |
| 2019 Q3 | 419.9 Million USD | 4.98% |
| 2019 Q2 | 400 Million USD | -4.17% |
| 2019 Q1 | 417.4 Million USD | 3.39% |
| 2018 Q2 | 354.9 Million USD | 11.92% |
| 2018 Q4 | 403.7 Million USD | 22.71% |
| 2018 FY | 1.4 Billion USD | 23.27% |
| 2018 Q1 | 317.1 Million USD | 3.53% |
| 2018 Q3 | 329 Million USD | -7.3% |
| 2017 Q2 | 270.4 Million USD | -1.53% |
| 2017 Q1 | 274.6 Million USD | 4.49% |
| 2017 FY | 1.13 Billion USD | 20.59% |
| 2017 Q4 | 306.3 Million USD | 6.28% |
| 2017 Q3 | 288.2 Million USD | 6.58% |
| 2016 Q4 | 262.8 Million USD | 13.96% |
| 2016 Q2 | 225.5 Million USD | -0.22% |
| 2016 Q3 | 230.6 Million USD | 2.26% |
| 2016 FY | 944.9 Million USD | 12.77% |
| 2016 Q1 | 226 Million USD | 6.15% |
| 2015 Q1 | 206.4 Million USD | -0.43% |
| 2015 Q2 | 212.7 Million USD | 3.05% |
| 2015 Q3 | 205.9 Million USD | -3.2% |
| 2015 FY | 837.9 Million USD | -3.58% |
| 2015 Q4 | 212.9 Million USD | 3.4% |
| 2014 Q4 | 207.3 Million USD | 2.88% |
| 2014 Q1 | 258.8 Million USD | 36.64% |
| 2014 FY | 869 Million USD | 17.16% |
| 2014 Q2 | 201.4 Million USD | -22.18% |
| 2014 Q3 | 201.5 Million USD | 0.05% |
| 2013 Q4 | 189.4 Million USD | 3.78% |
| 2013 Q2 | 186.7 Million USD | 1.97% |
| 2013 Q1 | 183.1 Million USD | -3.53% |
| 2013 FY | 741.7 Million USD | 7.15% |
| 2013 Q3 | 182.5 Million USD | -2.25% |
| 2012 Q1 | 162.6 Million USD | -0.49% |
| 2012 FY | 692.2 Million USD | 19.55% |
| 2012 Q4 | 189.8 Million USD | 6.21% |
| 2012 Q3 | 178.7 Million USD | 10.92% |
| 2012 Q2 | 161.1 Million USD | -0.92% |
| 2011 Q4 | 163.4 Million USD | 11.46% |
| 2011 Q3 | 146.6 Million USD | 5.85% |
| 2011 FY | 579 Million USD | 21.95% |
| 2011 Q2 | 138.5 Million USD | 6.13% |
| 2011 Q1 | 130.5 Million USD | 1.64% |
| 2010 Q2 | 117.1 Million USD | 5.69% |
| 2010 Q4 | 128.4 Million USD | 8.35% |
| 2010 Q3 | 118.5 Million USD | 1.2% |
| 2010 Q1 | 110.8 Million USD | 5.75% |
| 2010 FY | 474.8 Million USD | 27.08% |
| 2009 Q1 | 83.67 Million USD | 1.3% |
| 2009 FY | 373.61 Million USD | 20.54% |
| 2009 Q4 | 104.77 Million USD | 10.86% |
| 2009 Q3 | 94.51 Million USD | 4.27% |
| 2009 Q2 | 90.64 Million USD | 8.33% |
| 2008 Q4 | 82.6 Million USD | -2.29% |
| 2008 FY | 309.94 Million USD | 49.34% |
| 2008 Q3 | 84.54 Million USD | 8.58% |
| 2008 Q2 | 77.86 Million USD | 19.91% |
| 2008 Q1 | 64.93 Million USD | 5.04% |
| 2007 Q3 | 54.48 Million USD | 11.02% |
| 2007 Q2 | 49.07 Million USD | 16.38% |
| 2007 Q1 | 42.16 Million USD | 6.76% |
| 2007 FY | 207.54 Million USD | 47.74% |
| 2007 Q4 | 61.81 Million USD | 13.47% |
| 2006 Q3 | 36.55 Million USD | 6.05% |
| 2006 FY | 140.48 Million USD | 65.67% |
| 2006 Q2 | 34.47 Million USD | 15.07% |
| 2006 Q1 | 29.95 Million USD | 19.58% |
| 2006 Q4 | 39.49 Million USD | 8.05% |
| 2005 Q2 | 20.28 Million USD | 10.57% |
| 2005 Q3 | 21.1 Million USD | 4.04% |
| 2005 Q4 | 25.05 Million USD | 18.68% |
| 2005 Q1 | 18.34 Million USD | -2.69% |
| 2005 FY | 84.79 Million USD | 26.93% |
| 2004 Q4 | 18.85 Million USD | 9.41% |
| 2004 Q1 | 15.55 Million USD | 23.32% |
| 2004 Q2 | 15.16 Million USD | -2.52% |
| 2004 Q3 | 17.23 Million USD | 13.68% |
| 2004 FY | 66.8 Million USD | 19.49% |
| 2003 Q2 | 13.01 Million USD | -4.52% |
| 2003 FY | 55.9 Million USD | -3.03% |
| 2003 Q1 | 13.63 Million USD | -6.81% |
| 2003 Q4 | 12.61 Million USD | -24.25% |
| 2003 Q3 | 16.64 Million USD | 27.91% |
| 2002 Q3 | 15.58 Million USD | 8.0% |
| 2002 Q4 | 14.62 Million USD | -6.13% |
| 2002 Q2 | 14.42 Million USD | 10.85% |
| 2002 Q1 | 13.01 Million USD | 10.07% |
| 2002 FY | 57.65 Million USD | 31.52% |
| 2001 Q4 | 11.82 Million USD | 8.05% |
| 2001 Q2 | 11 Million USD | 9.3% |
| 2001 Q1 | 10.06 Million USD | -9.71% |
| 2001 FY | 43.83 Million USD | 23.06% |
| 2001 Q3 | 10.94 Million USD | -0.52% |
| 2000 Q4 | 11.14 Million USD | 12.5% |
| 2000 Q3 | 9.91 Million USD | 22.91% |
| 2000 FY | 35.62 Million USD | 56.85% |
| 2000 Q2 | 8.06 Million USD | 24.05% |
| 2000 Q1 | 6.5 Million USD | 0.0% |
| 1999 FY | 22.71 Million USD | -26.2% |
| 1998 FY | 30.77 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -701.074% |
| Accuray Incorporated | 142.61 Million USD | -1977.382% |
| Align Technology, Inc. | 2.07 Billion USD | -42.655% |
| Elevance Health Inc. | 36.23 Billion USD | 91.824% |
| AxoGen, Inc. | 149.33 Million USD | -1883.915% |
| Boston Scientific Corporation | 7.5 Billion USD | 60.529% |
| CVS Health Corporation | 40.68 Billion USD | 92.718% |
| Cardinal Health, Inc. | 5 Billion USD | 40.746% |
| Centene Corporation | 138.33 Billion USD | 97.858% |
| DaVita Inc. | 1.47 Billion USD | -100.999% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 93.48% |
| Hologic, Inc. | 1.26 Billion USD | -133.725% |
| Humana Inc. | 102.36 Billion USD | 97.106% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -171.1% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | -46.567% |
| Masimo Corporation | 867 Million USD | -241.719% |
| McKesson Corporation | 8.67 Billion USD | 65.848% |
| Patterson Companies, Inc. | 1.12 Billion USD | -162.81% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | -84.019% |
| ResMed Inc. | 1.36 Billion USD | -116.513% |
| Henry Schein, Inc. | 2.93 Billion USD | -0.875% |
| Teladoc Health, Inc. | 2.09 Billion USD | -41.692% |
| Universal Health Services, Inc. | 9.2 Billion USD | 67.826% |
| Veeva Systems Inc. | 1.25 Billion USD | -135.687% |
| Baxter International Inc. | 5.27 Billion USD | 43.803% |
| Becton, Dickinson and Company | 6.71 Billion USD | 55.86% |
| Danaher Corporation | 8.75 Billion USD | 66.16% |
| Stryker Corporation | 9.2 Billion USD | 67.828% |
| Medtronic plc | 16.12 Billion USD | 81.631% |